Latest filing published 01 Feb 2019 for Vyant Bio, Inc., €8,705.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Edmund Cannon: trading record in brief
Edmund Cannon is a declared insider of Vyant Bio, Inc., with filings sourced from SEC (Form 4). Between 22 May 2014 and 31 January 2019, the trades on record add up to 5 filings.
On the market, this insider has only ever bought: 1 purchase, €8,705 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 share grants. So far in 2019, the count stands at 1 purchase and no sales.
Most recently, on 1 February 2019, the filings show an open-market purchase worth €8,705 in Vyant Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Edmund Cannon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 43,479 shares@ US$0.23100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0000905718-19-000095:0Canonical exit: 1 May 2019 (T+90)
- 2,500 shares0Common Stock, par value $0.0001 per shareSEC:0001349929-17-000073:0
- 2,500 shares0Common Stock, par value $0.0001 per shareSEC:0001349929-17-000047:0
- 2,500 shares0Common Stock, par value $0.0001 per shareSEC:0001349929-16-000119:0
- 5,000 shares0Common Stock, par value $0.0001 per shareSEC:0000905718-14-000289:0
5 of 5 declarations
